CYCLOBENZAPRINE TREATMENT FOR AGITATION, PSYCHOSIS AND COGNITIVE DECLINE IN DEMENTIA AND… Application WO-2019116091-A1 World Intellectual Property Organisation (WIPO) 20 Jun 2019